FI884003A0 - NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. - Google Patents

NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.

Info

Publication number
FI884003A0
FI884003A0 FI884003A FI884003A FI884003A0 FI 884003 A0 FI884003 A0 FI 884003A0 FI 884003 A FI884003 A FI 884003A FI 884003 A FI884003 A FI 884003A FI 884003 A0 FI884003 A0 FI 884003A0
Authority
FI
Finland
Prior art keywords
pyridylethanolaminer
nya
foerfarande foer
acid addition
addition salts
Prior art date
Application number
FI884003A
Other languages
Finnish (fi)
Other versions
FI884003A (en
Inventor
Manfred Reiffen
Wolfgang Grell
Robert Sauter
Rudolf Hurnaus
Eckhard Rupprecht
Michael Mark
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI884003A0 publication Critical patent/FI884003A0/en
Publication of FI884003A publication Critical patent/FI884003A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Pyridylethanolamines of the formula <IMAGE> in which R denotes a carboxymethoxy, carbomethoxymethoxy, ethoxycarbonylmethoxy or 2-hydroxyethoxy group, their optical isomers, their diastereomers and their acid addition salts. The novel compounds of the above formula I, their optical isomers and their diastereomers and also their acid addition salts, in particular their physiologically tolerable acid addition salts with inorganic or organic acids, have useful pharmacological properties, namely an effect on the metabolism, preferably a hypoglycaemic and body fat-reducing effect, and also a lowering effect on the atherogenic beta -lipoproteins VLDL and LDL. The novel compounds of the above formula I can be prepared by processes which are known per se.
FI884003A 1987-09-02 1988-08-31 NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. FI884003A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873729284 DE3729284A1 (en) 1987-09-02 1987-09-02 NEW HETEROARYLETHANOLAMINES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
FI884003A0 true FI884003A0 (en) 1988-08-31
FI884003A FI884003A (en) 1989-03-03

Family

ID=6335037

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884003A FI884003A (en) 1987-09-02 1988-08-31 NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.

Country Status (13)

Country Link
EP (1) EP0305845B1 (en)
JP (1) JPH0196172A (en)
KR (1) KR890005056A (en)
AT (1) ATE81851T1 (en)
AU (1) AU617353B2 (en)
CA (1) CA1331005C (en)
DE (2) DE3729284A1 (en)
DK (1) DK486988A (en)
FI (1) FI884003A (en)
IL (1) IL87620A0 (en)
NZ (1) NZ226006A (en)
PT (1) PT88392B (en)
ZA (1) ZA886501B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918086A (en) * 1987-08-07 1990-04-17 Ciba-Geigy Corporation 1-nitro-2,2-diaminoethylene derivatives
DE4006794A1 (en) * 1990-03-03 1991-09-05 Bayer Ag METHOD FOR PRODUCING AMINOETHANOL DERIVATIVES
AU2003248614B2 (en) * 2002-07-17 2007-08-30 Lek Pharmaceuticals D.D. Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (en) * 1986-05-06 1987-11-12 Bayer Ag USE OF HETEROARYLETHYLAMINE FOR PERFORMANCE IN ANIMALS, HETEROARYLETHYLAMINE AND METHOD FOR THE PRODUCTION THEREOF
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
DE3627663A1 (en) * 1986-08-14 1988-03-03 Bayer Ag HETEROARYLETHYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PERFORMANCE IN ANIMALS
EP0281841B1 (en) * 1987-03-07 1990-11-14 Bayer Ag Process for preparation of 5-amino-4,6-dihalogenopyridines

Also Published As

Publication number Publication date
DE3875563D1 (en) 1992-12-03
DK486988A (en) 1989-03-03
CA1331005C (en) 1994-07-26
PT88392B (en) 1992-10-30
KR890005056A (en) 1989-05-11
ZA886501B (en) 2008-05-30
JPH0196172A (en) 1989-04-14
ATE81851T1 (en) 1992-11-15
DE3729284A1 (en) 1989-03-23
AU617353B2 (en) 1991-11-28
EP0305845A1 (en) 1989-03-08
PT88392A (en) 1989-07-31
DK486988D0 (en) 1988-09-01
IL87620A0 (en) 1989-01-31
NZ226006A (en) 1991-05-28
EP0305845B1 (en) 1992-10-28
FI884003A (en) 1989-03-03
AU2179088A (en) 1989-03-02

Similar Documents

Publication Publication Date Title
EP0742209A3 (en) A process for producing an optically active quinolinemevalonolactone and a process for producing an optically active quinolinemevalonic acid salt
FR2564859B1 (en) PROCESS FOR THE PREPARATION OF HYALURONIC ACID BY FERMENTATION.
ES2127765T3 (en) PROCEDURE FOR THE SEPARATION OF 5-METHYL-TETRAHYDROPHOLIC ACID.
ATE158798T1 (en) METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOBUTANE NUCLEOSIDES
PT80820B (en) METHOD FOR PREPARING DERIVATIVES OF 2-SUBSTITUTED 1,3-PROPYLIDENODPHOSPHONATE
SE8600017D0 (en) NEW COMPOUND
PL263885A1 (en) Method of obtaining novel derivatives of dihydrobenzofurane and chromate carbonamide
FI884003A0 (en) NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
YU47973B (en) S-ENANTIOMERIC GLUTARAMIDES AND THE PROCEDURE FOR OBTAINING THEM
FI864970A (en) NYA KRISTALLINA SALTER AV ARYLOXI-PROPANOLAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING.
FI870176A (en) NYA FOERENINGAR OCH DERAS FRAMSTAELLNINGSFOERFARANDEN.
DE59107451D1 (en) Process for the production of crystalline TACS
SE8803765L (en) NEW ISOPOLYPEPTIDES AND PROCEDURES FOR THE PREPARATION OF THE SAME
DK643189D0 (en) PREPARATION OF 5-ACYLAMINO-1,2,4-TRIAZOL-3-SULPHONAMIDES AND INTERMEDIATES
MA21305A1 (en) PROCESS FOR THE PREPARATION OF ACID (PYRIDYL-3) -3 IH, 3H-PYRRONO (I, 2-C) THIAZOLECARBOXYLIQUE-7 DEXTROCYRE.
ZA88640B (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,medicaments containing same,and the use thereof,and some intermediates formed in the preparation of the compounds mentioned
ATA214393A (en) PROCESS FOR THE PREPARATION OF 7-AMINO-3-CEPHEM-4-CARBONIC ACID DERIVATIVES
HU9302786D0 (en) New thiophene-2-carboxylic acid derivatives and process for preparing them
EP0429751A3 (en) Substituted 3-amino-sydnonimines, process for their preparation and their use
PT90831A (en) PROCESS FOR THE PREPARATION OF 2-AMINO-7-HYDROXYETRALIN ETERES
ATE71616T1 (en) PROCESS FOR THE MANUFACTURE OF E/Z MIXTURES OF 2-(BICYCLO(3.3.0&gt;OCTAN-3-YLIDENE)ACETIG|UREDERIVATIVES WITH A MAJOR E OR Z CONTENT.
DE59703279D1 (en) Production of an epoxy
HUT55774A (en) Process for producing 13,14-dihydro-berbane derivatives and pharmaceutical compositions containing them
OA08918A (en) Process for the enrichment of canallite by flotation.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT